

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.79706796 |
| 2 | regulation of T-helper 1 cell differentiation (GO:0045625) | 5.59068586 |
| 3 | cellular response to type I interferon (GO:0071357) | 5.48381965 |
| 4 | type I interferon signaling pathway (GO:0060337) | 5.48381965 |
| 5 | response to type I interferon (GO:0034340) | 5.41462590 |
| 6 | neutrophil activation involved in immune response (GO:0002283) | 5.30853273 |
| 7 | response to interferon-alpha (GO:0035455) | 5.30233582 |
| 8 | positive regulation of interferon-alpha production (GO:0032727) | 5.16300132 |
| 9 | regulation of interferon-alpha production (GO:0032647) | 4.87486494 |
| 10 | T-helper 1 type immune response (GO:0042088) | 4.82917360 |
| 11 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.77941534 |
| 12 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.77941534 |
| 13 | regulation of RIG-I signaling pathway (GO:0039535) | 4.75317499 |
| 14 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.75162158 |
| 15 | negative regulation of viral genome replication (GO:0045071) | 4.72203587 |
| 16 | immunoglobulin mediated immune response (GO:0016064) | 4.43306260 |
| 17 | response to interferon-beta (GO:0035456) | 4.36575424 |
| 18 | response to peptidoglycan (GO:0032494) | 4.34415703 |
| 19 | negative regulation of interleukin-12 production (GO:0032695) | 4.31731969 |
| 20 | myeloid dendritic cell differentiation (GO:0043011) | 4.19642556 |
| 21 | regulation of activation of Janus kinase activity (GO:0010533) | 4.18825064 |
| 22 | tryptophan catabolic process (GO:0006569) | 4.17441288 |
| 23 | indole-containing compound catabolic process (GO:0042436) | 4.17441288 |
| 24 | indolalkylamine catabolic process (GO:0046218) | 4.17441288 |
| 25 | regulation of chronic inflammatory response (GO:0002676) | 4.13688911 |
| 26 | cellular response to interferon-beta (GO:0035458) | 4.13165164 |
| 27 | NIK/NF-kappaB signaling (GO:0038061) | 4.07636080 |
| 28 | cellular response to exogenous dsRNA (GO:0071360) | 4.05909342 |
| 29 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 4.05089210 |
| 30 | neutrophil activation (GO:0042119) | 4.04771768 |
| 31 | positive regulation by symbiont of host defense response (GO:0052509) | 4.04164692 |
| 32 | modulation by symbiont of host defense response (GO:0052031) | 4.04164692 |
| 33 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.04164692 |
| 34 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.04164692 |
| 35 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.04164692 |
| 36 | modulation by symbiont of host immune response (GO:0052553) | 4.04164692 |
| 37 | kynurenine metabolic process (GO:0070189) | 4.04013704 |
| 38 | granulocyte activation (GO:0036230) | 4.02513842 |
| 39 | positive regulation of type 2 immune response (GO:0002830) | 4.02226090 |
| 40 | natural killer cell mediated cytotoxicity (GO:0042267) | 4.01707985 |
| 41 | natural killer cell mediated immunity (GO:0002228) | 4.01707985 |
| 42 | defense response to protozoan (GO:0042832) | 3.98754047 |
| 43 | myeloid dendritic cell activation (GO:0001773) | 3.98701389 |
| 44 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.96212835 |
| 45 | positive regulation of interleukin-12 production (GO:0032735) | 3.85302579 |
| 46 | positive regulation of antigen processing and presentation (GO:0002579) | 3.82944687 |
| 47 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.79950913 |
| 48 | cellular response to interferon-alpha (GO:0035457) | 3.79751130 |
| 49 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.79060739 |
| 50 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.73884426 |
| 51 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.72383210 |
| 52 | positive regulation of interferon-beta production (GO:0032728) | 3.72222662 |
| 53 | cellular response to zinc ion (GO:0071294) | 3.66399085 |
| 54 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.64931693 |
| 55 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.63633306 |
| 56 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.62254684 |
| 57 | tryptophan metabolic process (GO:0006568) | 3.59890747 |
| 58 | B cell mediated immunity (GO:0019724) | 3.58302223 |
| 59 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.57527160 |
| 60 | dendritic cell differentiation (GO:0097028) | 3.50579094 |
| 61 | * positive regulation of natural killer cell differentiation (GO:0032825) | 3.47190526 |
| 62 | cellular response to virus (GO:0098586) | 3.45444772 |
| 63 | response to protozoan (GO:0001562) | 3.43566103 |
| 64 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.41877703 |
| 65 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.41439337 |
| 66 | positive regulation of heat generation (GO:0031652) | 3.41300098 |
| 67 | negative regulation of interleukin-17 production (GO:0032700) | 3.41228084 |
| 68 | regulation of T-helper cell differentiation (GO:0045622) | 3.38991591 |
| 69 | response to muramyl dipeptide (GO:0032495) | 3.38937914 |
| 70 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.36817405 |
| 71 | regulation of antigen processing and presentation (GO:0002577) | 3.36500481 |
| 72 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.36368396 |
| 73 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.33041721 |
| 74 | response to host immune response (GO:0052572) | 3.31689345 |
| 75 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.31689345 |
| 76 | monocyte chemotaxis (GO:0002548) | 3.31418534 |
| 77 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.31146701 |
| 78 | positive regulation of T cell cytokine production (GO:0002726) | 3.31035078 |
| 79 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.27576878 |
| 80 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.26577043 |
| 81 | defense response to virus (GO:0051607) | 3.25331986 |
| 82 | positive regulation of interleukin-1 secretion (GO:0050716) | 3.25262727 |
| 83 | indolalkylamine metabolic process (GO:0006586) | 3.23944478 |
| 84 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.22955600 |
| 85 | interferon-gamma secretion (GO:0072643) | 3.21333639 |
| 86 | regulation of hypersensitivity (GO:0002883) | 3.20535452 |
| 87 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.19608300 |
| 88 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.19274093 |
| 89 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.19266488 |
| 90 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.18761050 |
| 91 | myeloid cell activation involved in immune response (GO:0002275) | 3.17599899 |
| 92 | regulation of T-helper 1 type immune response (GO:0002825) | 3.17223292 |
| 93 | regulation of interleukin-1 beta secretion (GO:0050706) | 3.14296454 |
| 94 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.13738872 |
| 95 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.11906304 |
| 96 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.11221158 |
| 97 | respiratory burst (GO:0045730) | 3.10726667 |
| 98 | macrophage activation involved in immune response (GO:0002281) | 3.09783431 |
| 99 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.08978709 |
| 100 | negative regulation of cell killing (GO:0031342) | 3.08978709 |
| 101 | T cell migration (GO:0072678) | 3.07560889 |
| 102 | cellular biogenic amine catabolic process (GO:0042402) | 3.06807999 |
| 103 | amine catabolic process (GO:0009310) | 3.06807999 |
| 104 | leukocyte mediated cytotoxicity (GO:0001909) | 3.05798253 |
| 105 | cellular response to interferon-gamma (GO:0071346) | 3.05361518 |
| 106 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.02632866 |
| 107 | regulation of interleukin-12 production (GO:0032655) | 3.02583559 |
| 108 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.02504345 |
| 109 | positive regulation of defense response to virus by host (GO:0002230) | 3.00935478 |
| 110 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.00444596 |
| 111 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.99388889 |
| 112 | response to host (GO:0075136) | 2.99051123 |
| 113 | response to host defenses (GO:0052200) | 2.99051123 |
| 114 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.99051123 |
| 115 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.97767686 |
| 116 | interferon-gamma production (GO:0032609) | 2.97034765 |
| 117 | positive regulation of response to biotic stimulus (GO:0002833) | 2.96670498 |
| 118 | response to interferon-gamma (GO:0034341) | 2.96358055 |
| 119 | lymphocyte chemotaxis (GO:0048247) | 2.96319645 |
| 120 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.95879412 |
| 121 | regulation of immunoglobulin secretion (GO:0051023) | 2.95864965 |
| 122 | positive regulation of B cell differentiation (GO:0045579) | 2.95388352 |
| 123 | germinal center formation (GO:0002467) | 2.93282642 |
| 124 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.90989323 |
| 125 | regulation of chemokine biosynthetic process (GO:0045073) | 2.90942640 |
| 126 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.90545212 |
| 127 | myeloid leukocyte activation (GO:0002274) | 2.88302880 |
| 128 | regulation of vitamin metabolic process (GO:0030656) | 2.87732832 |
| 129 | positive regulation of interleukin-10 production (GO:0032733) | 2.86202553 |
| 130 | regulation of interleukin-1 secretion (GO:0050704) | 2.85769316 |
| 131 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.85152988 |
| 132 | regulation of fever generation (GO:0031620) | 2.84180965 |
| 133 | negative regulation of T cell mediated immunity (GO:0002710) | 2.81456545 |
| 134 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.79160328 |
| 135 | regulation of T cell tolerance induction (GO:0002664) | 2.78182742 |
| 136 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.76608339 |
| 137 | * regulation of defense response to virus by host (GO:0050691) | 2.74570025 |
| 138 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.72192304 |
| 139 | regulation of interferon-beta production (GO:0032648) | 2.70848393 |
| 140 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.70163661 |
| 141 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.69397562 |
| 142 | natural killer cell activation involved in immune response (GO:0002323) | 2.68648487 |
| 143 | regulation of heat generation (GO:0031650) | 2.67543774 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 8.32584185 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.71425626 |
| 3 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.83218882 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.52829420 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.50313918 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.20757018 |
| 7 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.87671963 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.36949412 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.27549039 |
| 10 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.23086478 |
| 11 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.11189628 |
| 12 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.07536694 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.97173245 |
| 14 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.89908436 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.86607413 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 2.78944003 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.71302037 |
| 18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.43021242 |
| 19 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.41927551 |
| 20 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.35891318 |
| 21 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.25319669 |
| 22 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.21613313 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.10939353 |
| 24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92823756 |
| 25 | MYB_26560356_Chip-Seq_TH2_Human | 1.87232725 |
| 26 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.84319628 |
| 27 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.79646565 |
| 28 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71971503 |
| 29 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.68212812 |
| 30 | MAF_26560356_Chip-Seq_TH1_Human | 1.67037483 |
| 31 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63194881 |
| 32 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.63194135 |
| 33 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.61540884 |
| 34 | MYB_26560356_Chip-Seq_TH1_Human | 1.56036844 |
| 35 | VDR_22108803_ChIP-Seq_LS180_Human | 1.55697176 |
| 36 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.54928811 |
| 37 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.53184346 |
| 38 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.51118867 |
| 39 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.49793720 |
| 40 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.45934126 |
| 41 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.44982685 |
| 42 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.44927613 |
| 43 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.44760614 |
| 44 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.43905649 |
| 45 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.43350713 |
| 46 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40468276 |
| 47 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.38503562 |
| 48 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.37687533 |
| 49 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.36583079 |
| 50 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36420402 |
| 51 | SPI1_23127762_ChIP-Seq_K562_Human | 1.32469798 |
| 52 | GATA3_26560356_Chip-Seq_TH2_Human | 1.30688722 |
| 53 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.28132575 |
| 54 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.28065749 |
| 55 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27935386 |
| 56 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.26998602 |
| 57 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.26931250 |
| 58 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.26741185 |
| 59 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.26185199 |
| 60 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.25737014 |
| 61 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.24378045 |
| 62 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.24197005 |
| 63 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23487806 |
| 64 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.23144894 |
| 65 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.23106037 |
| 66 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21875390 |
| 67 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.20757662 |
| 68 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18123751 |
| 69 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.16920710 |
| 70 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.15296964 |
| 71 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.12945651 |
| 72 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.12726529 |
| 73 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.11566235 |
| 74 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.09913278 |
| 75 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08513951 |
| 76 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.08444498 |
| 77 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.08391834 |
| 78 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.08378423 |
| 79 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.06729632 |
| 80 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05094236 |
| 81 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.04518199 |
| 82 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.03839590 |
| 83 | P300_19829295_ChIP-Seq_ESCs_Human | 1.03031150 |
| 84 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.02953592 |
| 85 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.02862970 |
| 86 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.02826645 |
| 87 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.02653135 |
| 88 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.02600562 |
| 89 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02394089 |
| 90 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.00856660 |
| 91 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.00492758 |
| 92 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.99968099 |
| 93 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99462045 |
| 94 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.99362555 |
| 95 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.99055998 |
| 96 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.99034791 |
| 97 | CJUN_26792858_Chip-Seq_BT549_Human | 0.97656822 |
| 98 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96399329 |
| 99 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.96321163 |
| 100 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.96321163 |
| 101 | * TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.96101262 |
| 102 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.96093753 |
| 103 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.96093753 |
| 104 | UTX_26944678_Chip-Seq_JUKART_Human | 0.94988704 |
| 105 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.93485545 |
| 106 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.92776405 |
| 107 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.92776405 |
| 108 | * GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91872252 |
| 109 | GATA3_26560356_Chip-Seq_TH1_Human | 0.91713587 |
| 110 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.91227322 |
| 111 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.88535696 |
| 112 | MAF_26560356_Chip-Seq_TH2_Human | 0.88441342 |
| 113 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.88420128 |
| 114 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.88389592 |
| 115 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.87070495 |
| 116 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.86942367 |
| 117 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.86942367 |
| 118 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.86489550 |
| 119 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.85294129 |
| 120 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.85218624 |
| 121 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.84920714 |
| 122 | AR_20517297_ChIP-Seq_VCAP_Human | 0.84726747 |
| 123 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.83549276 |
| 124 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.83281283 |
| 125 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82705758 |
| 126 | AR_25329375_ChIP-Seq_VCAP_Human | 0.82482159 |
| 127 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.80325179 |
| 128 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.79987039 |
| 129 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78344982 |
| 130 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.78197428 |
| 131 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.76099039 |
| 132 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.74844061 |
| 133 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.71130707 |
| 134 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.69406972 |
| 135 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.68137620 |
| 136 | * EGR1_19032775_ChIP-ChIP_M12_Human | 0.65455005 |
| 137 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.65379074 |
| 138 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.63389705 |
| 139 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.63156906 |
| 140 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.62512311 |
| 141 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.61162369 |
| 142 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.60758199 |
| 143 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.60601805 |
| 144 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.59389313 |
| 145 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.58196958 |
| 146 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.57997395 |
| 147 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.57399926 |
| 148 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.56922105 |
| 149 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.56370621 |
| 150 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.55887651 |
| 151 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.54315472 |
| 152 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.54315472 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.41248005 |
| 2 | * MP0009785_altered_susceptibility_to | 4.13145536 |
| 3 | * MP0002148_abnormal_hypersensitivity_rea | 3.83289713 |
| 4 | MP0003436_decreased_susceptibility_to | 3.42455264 |
| 5 | * MP0000685_abnormal_immune_system | 3.38153265 |
| 6 | MP0005671_abnormal_response_to | 3.22655658 |
| 7 | * MP0005025_abnormal_response_to | 3.15101301 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.12603731 |
| 9 | MP0003724_increased_susceptibility_to | 3.00524372 |
| 10 | * MP0005387_immune_system_phenotype | 2.98451636 |
| 11 | * MP0001790_abnormal_immune_system | 2.98451636 |
| 12 | MP0006082_CNS_inflammation | 2.86180715 |
| 13 | MP0002419_abnormal_innate_immunity | 2.84940981 |
| 14 | * MP0001800_abnormal_humoral_immune | 2.66621193 |
| 15 | * MP0002452_abnormal_antigen_presenting | 2.66382400 |
| 16 | MP0004510_myositis | 2.62162694 |
| 17 | * MP0002723_abnormal_immune_serum | 2.61878019 |
| 18 | MP0003195_calcinosis | 2.46011848 |
| 19 | * MP0001819_abnormal_immune_cell | 2.36412233 |
| 20 | MP0002166_altered_tumor_susceptibility | 2.32565349 |
| 21 | MP0002420_abnormal_adaptive_immunity | 2.32284434 |
| 22 | MP0002006_tumorigenesis | 2.22115945 |
| 23 | MP0006054_spinal_hemorrhage | 2.17738884 |
| 24 | MP0001853_heart_inflammation | 2.11973659 |
| 25 | MP0003303_peritoneal_inflammation | 2.04666032 |
| 26 | MP0009764_decreased_sensitivity_to | 2.01027740 |
| 27 | MP0005464_abnormal_platelet_physiology | 1.97445158 |
| 28 | MP0010155_abnormal_intestine_physiology | 1.95031247 |
| 29 | MP0001348_abnormal_lacrimal_gland | 1.87508035 |
| 30 | MP0002139_abnormal_hepatobiliary_system | 1.87296630 |
| 31 | MP0000716_abnormal_immune_system | 1.84598010 |
| 32 | MP0001545_abnormal_hematopoietic_system | 1.84547237 |
| 33 | MP0005397_hematopoietic_system_phenotyp | 1.84547237 |
| 34 | MP0001845_abnormal_inflammatory_respons | 1.84528875 |
| 35 | MP0002398_abnormal_bone_marrow | 1.81910501 |
| 36 | MP0005058_abnormal_lysosome_morphology | 1.80054190 |
| 37 | MP0005310_abnormal_salivary_gland | 1.79830089 |
| 38 | MP0002332_abnormal_exercise_endurance | 1.79598510 |
| 39 | MP0001533_abnormal_skeleton_physiology | 1.76297741 |
| 40 | MP0008469_abnormal_protein_level | 1.74517682 |
| 41 | MP0004947_skin_inflammation | 1.67143174 |
| 42 | MP0002405_respiratory_system_inflammati | 1.66242017 |
| 43 | MP0008004_abnormal_stomach_pH | 1.58923402 |
| 44 | MP0002138_abnormal_hepatobiliary_system | 1.55816901 |
| 45 | MP0002429_abnormal_blood_cell | 1.51597780 |
| 46 | MP0002396_abnormal_hematopoietic_system | 1.50588949 |
| 47 | MP0002163_abnormal_gland_morphology | 1.50560165 |
| 48 | MP0001501_abnormal_sleep_pattern | 1.46879024 |
| 49 | MP0000343_altered_response_to | 1.40436562 |
| 50 | MP0009333_abnormal_splenocyte_physiolog | 1.38820285 |
| 51 | MP0000689_abnormal_spleen_morphology | 1.38763744 |
| 52 | MP0003763_abnormal_thymus_physiology | 1.35561158 |
| 53 | MP0003191_abnormal_cellular_cholesterol | 1.35343832 |
| 54 | MP0001873_stomach_inflammation | 1.34363152 |
| 55 | MP0009278_abnormal_bone_marrow | 1.33802621 |
| 56 | MP0003806_abnormal_nucleotide_metabolis | 1.33389666 |
| 57 | MP0009840_abnormal_foam_cell | 1.32878671 |
| 58 | MP0004808_abnormal_hematopoietic_stem | 1.32446425 |
| 59 | * MP0002722_abnormal_immune_system | 1.30440963 |
| 60 | MP0003075_altered_response_to | 1.29276929 |
| 61 | MP0003448_altered_tumor_morphology | 1.27063069 |
| 62 | MP0002254_reproductive_system_inflammat | 1.26698515 |
| 63 | MP0004782_abnormal_surfactant_physiolog | 1.24895399 |
| 64 | MP0003172_abnormal_lysosome_physiology | 1.18657062 |
| 65 | MP0002277_abnormal_respiratory_mucosa | 1.16682239 |
| 66 | MP0003186_abnormal_redox_activity | 1.16496098 |
| 67 | MP0005174_abnormal_tail_pigmentation | 1.15427655 |
| 68 | MP0005084_abnormal_gallbladder_morpholo | 1.14310734 |
| 69 | MP0000858_altered_metastatic_potential | 1.12350299 |
| 70 | MP0003656_abnormal_erythrocyte_physiolo | 1.11358000 |
| 71 | MP0001346_abnormal_lacrimal_gland | 1.07128188 |
| 72 | MP0009763_increased_sensitivity_to | 1.07007838 |
| 73 | MP0003950_abnormal_plasma_membrane | 1.06551525 |
| 74 | MP0002998_abnormal_bone_remodeling | 0.99247861 |
| 75 | MP0000490_abnormal_crypts_of | 0.96998668 |
| 76 | MP0003828_pulmonary_edema | 0.95854184 |
| 77 | MP0003045_fibrosis | 0.90986755 |
| 78 | MP0002837_dystrophic_cardiac_calcinosis | 0.89333146 |
| 79 | MP0005451_abnormal_body_composition | 0.88901937 |
| 80 | MP0005166_decreased_susceptibility_to | 0.88620501 |
| 81 | MP0008875_abnormal_xenobiotic_pharmacok | 0.88226430 |
| 82 | MP0005167_abnormal_blood-brain_barrier | 0.87844948 |
| 83 | MP0003866_abnormal_defecation | 0.87364520 |
| 84 | MP0005379_endocrine/exocrine_gland_phen | 0.87261602 |
| 85 | MP0004043_abnormal_pH_regulation | 0.85840529 |
| 86 | MP0005266_abnormal_metabolism | 0.84053694 |
| 87 | MP0003252_abnormal_bile_duct | 0.81931069 |
| 88 | MP0004883_abnormal_blood_vessel | 0.80910743 |
| 89 | MP0010307_abnormal_tumor_latency | 0.80595310 |
| 90 | MP0001542_abnormal_bone_strength | 0.78603861 |
| 91 | MP0003300_gastrointestinal_ulcer | 0.75217615 |
| 92 | MP0005390_skeleton_phenotype | 0.74132981 |
| 93 | MP0000230_abnormal_systemic_arterial | 0.73766602 |
| 94 | * MP0000703_abnormal_thymus_morphology | 0.71800126 |
| 95 | MP0005647_abnormal_sex_gland | 0.70805628 |
| 96 | MP0000249_abnormal_blood_vessel | 0.70513665 |
| 97 | MP0003183_abnormal_peptide_metabolism | 0.69016927 |
| 98 | MP0001764_abnormal_homeostasis | 0.68577919 |
| 99 | MP0001881_abnormal_mammary_gland | 0.68292002 |
| 100 | MP0000569_abnormal_digit_pigmentation | 0.67900520 |
| 101 | MP0005410_abnormal_fertilization | 0.67745780 |
| 102 | MP0000371_diluted_coat_color | 0.67416950 |
| 103 | MP0003646_muscle_fatigue | 0.67164208 |
| 104 | MP0005535_abnormal_body_temperature | 0.66537131 |
| 105 | MP0010386_abnormal_urinary_bladder | 0.65901037 |
| 106 | MP0003943_abnormal_hepatobiliary_system | 0.65587261 |
| 107 | MP0010352_gastrointestinal_tract_polyps | 0.65397924 |
| 108 | MP0008057_abnormal_DNA_replication | 0.63131563 |
| 109 | MP0001879_abnormal_lymphatic_vessel | 0.62883885 |
| 110 | MP0005164_abnormal_response_to | 0.62344902 |
| 111 | MP0003091_abnormal_cell_migration | 0.62166485 |
| 112 | MP0009765_abnormal_xenobiotic_induced | 0.61199603 |
| 113 | MP0003690_abnormal_glial_cell | 0.60815050 |
| 114 | MP0005376_homeostasis/metabolism_phenot | 0.60372678 |
| 115 | MP0003221_abnormal_cardiomyocyte_apopto | 0.59674084 |
| 116 | MP0002933_joint_inflammation | 0.58560124 |
| 117 | MP0002136_abnormal_kidney_physiology | 0.57650952 |
| 118 | MP0005365_abnormal_bile_salt | 0.56762682 |
| 119 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.56729441 |
| 120 | MP0003566_abnormal_cell_adhesion | 0.56573311 |
| 121 | MP0000604_amyloidosis | 0.56300274 |
| 122 | MP0002019_abnormal_tumor_incidence | 0.54238670 |
| 123 | MP0002693_abnormal_pancreas_physiology | 0.53461389 |
| 124 | MP0005319_abnormal_enzyme/_coenzyme | 0.51755248 |
| 125 | MP0001663_abnormal_digestive_system | 0.51383013 |
| 126 | MP0003453_abnormal_keratinocyte_physiol | 0.49625191 |
| 127 | MP0005165_increased_susceptibility_to | 0.49212964 |
| 128 | MP0000465_gastrointestinal_hemorrhage | 0.47431103 |
| 129 | MP0000015_abnormal_ear_pigmentation | 0.46641290 |
| 130 | MP0000767_abnormal_smooth_muscle | 0.46511579 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.00937635 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.84318416 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.46353779 |
| 4 | Eczematoid dermatitis (HP:0000976) | 5.38549891 |
| 5 | Autoimmune thrombocytopenia (HP:0001973) | 5.30402742 |
| 6 | Increased IgM level (HP:0003496) | 4.99268510 |
| 7 | Myositis (HP:0100614) | 4.64370386 |
| 8 | Abnormality of macrophages (HP:0004311) | 4.48214045 |
| 9 | Chronic otitis media (HP:0000389) | 4.09580378 |
| 10 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.09213094 |
| 11 | Orchitis (HP:0100796) | 4.05010070 |
| 12 | Abnormality of glycolipid metabolism (HP:0010969) | 4.03556433 |
| 13 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.03556433 |
| 14 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.03556433 |
| 15 | Mediastinal lymphadenopathy (HP:0100721) | 4.03480410 |
| 16 | Vasculitis (HP:0002633) | 4.00987185 |
| 17 | Retrobulbar optic neuritis (HP:0100654) | 3.92127887 |
| 18 | Optic neuritis (HP:0100653) | 3.92127887 |
| 19 | Recurrent fungal infections (HP:0002841) | 3.88979772 |
| 20 | Recurrent skin infections (HP:0001581) | 3.85728103 |
| 21 | Recurrent viral infections (HP:0004429) | 3.83555021 |
| 22 | Hypergammaglobulinemia (HP:0010702) | 3.80150135 |
| 23 | Basal ganglia calcification (HP:0002135) | 3.78295286 |
| 24 | Vacuolated lymphocytes (HP:0001922) | 3.60324849 |
| 25 | Thrombocytosis (HP:0001894) | 3.57599008 |
| 26 | Systemic lupus erythematosus (HP:0002725) | 3.23530774 |
| 27 | Tetraparesis (HP:0002273) | 3.20941718 |
| 28 | Autoimmune hemolytic anemia (HP:0001890) | 3.11497142 |
| 29 | Interstitial pulmonary disease (HP:0006530) | 3.10527937 |
| 30 | Petechiae (HP:0000967) | 3.06677196 |
| 31 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.05120515 |
| 32 | Cellulitis (HP:0100658) | 3.01373252 |
| 33 | Periodontitis (HP:0000704) | 2.97139132 |
| 34 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.96275692 |
| 35 | Gastrointestinal infarctions (HP:0005244) | 2.92560828 |
| 36 | Gingivitis (HP:0000230) | 2.91055715 |
| 37 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.90816283 |
| 38 | Recurrent cutaneous fungal infections (HP:0011370) | 2.90816283 |
| 39 | Obstructive lung disease (HP:0006536) | 2.89770434 |
| 40 | Chronic obstructive pulmonary disease (HP:0006510) | 2.89770434 |
| 41 | Nasal polyposis (HP:0100582) | 2.86865990 |
| 42 | Gangrene (HP:0100758) | 2.81812231 |
| 43 | Abnormality of the nasal mucosa (HP:0000433) | 2.80739455 |
| 44 | Abnormality of T cell number (HP:0011839) | 2.80669584 |
| 45 | Arterial thrombosis (HP:0004420) | 2.80069464 |
| 46 | Pulmonary infiltrates (HP:0002113) | 2.79867381 |
| 47 | Abnormality of T cell physiology (HP:0011840) | 2.78848847 |
| 48 | Increased cerebral lipofuscin (HP:0011813) | 2.73089205 |
| 49 | Meningitis (HP:0001287) | 2.72364359 |
| 50 | Porencephaly (HP:0002132) | 2.71540286 |
| 51 | Stomatitis (HP:0010280) | 2.66144028 |
| 52 | Dysostosis multiplex (HP:0000943) | 2.63450440 |
| 53 | Gingival bleeding (HP:0000225) | 2.61294907 |
| 54 | Urticaria (HP:0001025) | 2.60468806 |
| 55 | Hemoptysis (HP:0002105) | 2.59798878 |
| 56 | T lymphocytopenia (HP:0005403) | 2.56424140 |
| 57 | Abnormality of B cell number (HP:0010975) | 2.56394471 |
| 58 | Pustule (HP:0200039) | 2.54774677 |
| 59 | Recurrent pneumonia (HP:0006532) | 2.52830166 |
| 60 | Parakeratosis (HP:0001036) | 2.51670743 |
| 61 | Increased serum ferritin (HP:0003281) | 2.51505577 |
| 62 | Vertebral compression fractures (HP:0002953) | 2.48910643 |
| 63 | Recurrent bronchitis (HP:0002837) | 2.48332470 |
| 64 | Disinhibition (HP:0000734) | 2.47164684 |
| 65 | Stomach cancer (HP:0012126) | 2.46069708 |
| 66 | Leukocytosis (HP:0001974) | 2.44652426 |
| 67 | Recurrent lower respiratory tract infections (HP:0002783) | 2.44642077 |
| 68 | Agammaglobulinemia (HP:0004432) | 2.44235043 |
| 69 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.43715335 |
| 70 | Increased IgE level (HP:0003212) | 2.43660451 |
| 71 | Eosinophilia (HP:0001880) | 2.42937256 |
| 72 | Hematochezia (HP:0002573) | 2.39482090 |
| 73 | Alveolar cell carcinoma (HP:0006519) | 2.38135329 |
| 74 | Keratoconjunctivitis sicca (HP:0001097) | 2.34117073 |
| 75 | Abnormality of iron homeostasis (HP:0011031) | 2.34103326 |
| 76 | Poor head control (HP:0002421) | 2.33845601 |
| 77 | Colitis (HP:0002583) | 2.29040821 |
| 78 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.28198700 |
| 79 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.28198700 |
| 80 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.28198700 |
| 81 | Keratoconjunctivitis (HP:0001096) | 2.27832118 |
| 82 | Episodic fever (HP:0001954) | 2.24385485 |
| 83 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.24066766 |
| 84 | Polyneuropathy (HP:0001271) | 2.23489369 |
| 85 | Keratitis (HP:0000491) | 2.22278705 |
| 86 | Osteomyelitis (HP:0002754) | 2.21839402 |
| 87 | Chronic sinusitis (HP:0011109) | 2.21720368 |
| 88 | Neutropenia (HP:0001875) | 2.20792064 |
| 89 | Joint swelling (HP:0001386) | 2.20001121 |
| 90 | Abnormality of T cells (HP:0002843) | 2.18750049 |
| 91 | Abnormality of the prostate (HP:0008775) | 2.17974985 |
| 92 | IgG deficiency (HP:0004315) | 2.17458208 |
| 93 | Prostate neoplasm (HP:0100787) | 2.17129694 |
| 94 | IgA deficiency (HP:0002720) | 2.16909813 |
| 95 | Epistaxis (HP:0000421) | 2.16085709 |
| 96 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.15781437 |
| 97 | Granulocytopenia (HP:0001913) | 2.15155740 |
| 98 | Chest pain (HP:0100749) | 2.13841235 |
| 99 | Purpura (HP:0000979) | 2.13430298 |
| 100 | Axonal loss (HP:0003447) | 2.12128667 |
| 101 | Inflammation of the large intestine (HP:0002037) | 2.11804069 |
| 102 | Premature loss of primary teeth (HP:0006323) | 2.11425423 |
| 103 | Spontaneous hematomas (HP:0007420) | 2.10367149 |
| 104 | Encephalitis (HP:0002383) | 2.09339100 |
| 105 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.09272411 |
| 106 | Loss of speech (HP:0002371) | 2.08500569 |
| 107 | Abnormality of the pericardium (HP:0001697) | 2.07846121 |
| 108 | Mutism (HP:0002300) | 2.07578914 |
| 109 | Reduced antithrombin III activity (HP:0001976) | 2.07305702 |
| 110 | Abnormality of eosinophils (HP:0001879) | 2.06078940 |
| 111 | Thick nail (HP:0001805) | 2.06071324 |
| 112 | Amaurosis fugax (HP:0100576) | 2.05584720 |
| 113 | Abnormality of the pleura (HP:0002103) | 2.04760377 |
| 114 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.03233094 |
| 115 | Gastrointestinal inflammation (HP:0004386) | 2.02897506 |
| 116 | Anorexia (HP:0002039) | 2.02540706 |
| 117 | Panhypogammaglobulinemia (HP:0003139) | 2.01807622 |
| 118 | Mucopolysacchariduria (HP:0008155) | 1.99885147 |
| 119 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.99885147 |
| 120 | Skin ulcer (HP:0200042) | 1.99481830 |
| 121 | Cleft eyelid (HP:0000625) | 1.98579058 |
| 122 | Pulmonary embolism (HP:0002204) | 1.96278332 |
| 123 | Abnormality of lateral ventricle (HP:0030047) | 1.95858545 |
| 124 | Prolonged bleeding time (HP:0003010) | 1.95339100 |
| 125 | Nausea (HP:0002018) | 1.94881490 |
| 126 | Neoplasm of head and neck (HP:0012288) | 1.94350748 |
| 127 | Esophageal neoplasm (HP:0100751) | 1.94350748 |
| 128 | Chronic diarrhea (HP:0002028) | 1.94047345 |
| 129 | Albinism (HP:0001022) | 1.94013895 |
| 130 | Abnormality of the basal ganglia (HP:0002134) | 1.93971261 |
| 131 | Vertigo (HP:0002321) | 1.93315598 |
| 132 | B lymphocytopenia (HP:0010976) | 1.93157933 |
| 133 | Abnormality of the endocardium (HP:0004306) | 1.82571731 |
| 134 | Abolished electroretinogram (ERG) (HP:0000550) | 1.75815799 |
| 135 | Pancreatic cysts (HP:0001737) | 1.71967085 |
| 136 | Abnormality of the renal cortex (HP:0011035) | 1.71009383 |
| 137 | 3-Methylglutaconic aciduria (HP:0003535) | 1.69612584 |
| 138 | Hyperventilation (HP:0002883) | 1.69547149 |
| 139 | Inappropriate behavior (HP:0000719) | 1.69303046 |
| 140 | Pancreatitis (HP:0001733) | 1.67512289 |
| 141 | Metaphyseal irregularity (HP:0003025) | 1.64729884 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 5.12297981 |
| 2 | TYK2 | 4.04603312 |
| 3 | FRK | 3.92466407 |
| 4 | TBK1 | 3.77269791 |
| 5 | IKBKE | 3.19249130 |
| 6 | JAK3 | 3.16609858 |
| 7 | IRAK4 | 3.13740186 |
| 8 | PIM2 | 2.94068164 |
| 9 | IKBKB | 2.85657386 |
| 10 | KIT | 2.80536107 |
| 11 | JAK1 | 2.40015395 |
| 12 | RIPK4 | 2.37329542 |
| 13 | BLK | 2.36177505 |
| 14 | MAP3K13 | 2.33250190 |
| 15 | PBK | 2.06192712 |
| 16 | IRAK3 | 2.04200050 |
| 17 | TIE1 | 1.91171631 |
| 18 | MAP4K1 | 1.87120454 |
| 19 | CHUK | 1.76741741 |
| 20 | TEC | 1.75322403 |
| 21 | FLT3 | 1.63889974 |
| 22 | TXK | 1.62193665 |
| 23 | BTK | 1.62173898 |
| 24 | TLK1 | 1.56313686 |
| 25 | SYK | 1.55868903 |
| 26 | NME2 | 1.53623203 |
| 27 | ZAP70 | 1.41372729 |
| 28 | INSRR | 1.38195864 |
| 29 | EIF2AK2 | 1.36295278 |
| 30 | BMPR2 | 1.31019882 |
| 31 | CSF1R | 1.30410638 |
| 32 | FGFR4 | 1.26318783 |
| 33 | TRIM28 | 1.25312530 |
| 34 | MATK | 1.24194768 |
| 35 | ERN1 | 1.21642686 |
| 36 | EPHB1 | 1.17109111 |
| 37 | ARAF | 1.14310150 |
| 38 | NEK9 | 1.13828149 |
| 39 | TAOK2 | 1.12361027 |
| 40 | PIM1 | 1.11671338 |
| 41 | MST4 | 1.10346473 |
| 42 | HCK | 1.10059670 |
| 43 | TRPM7 | 1.10043900 |
| 44 | DAPK2 | 1.09523121 |
| 45 | IRAK1 | 1.08409733 |
| 46 | TAOK3 | 1.07651516 |
| 47 | TNIK | 1.07466925 |
| 48 | NLK | 1.07433043 |
| 49 | MAP3K3 | 1.07090940 |
| 50 | FGR | 1.07076068 |
| 51 | MAP4K2 | 1.06799316 |
| 52 | RPS6KA4 | 1.06576080 |
| 53 | TGFBR2 | 1.06293038 |
| 54 | EPHA3 | 1.06125401 |
| 55 | FGFR3 | 1.04886302 |
| 56 | ZAK | 1.00142839 |
| 57 | LYN | 0.99715336 |
| 58 | LCK | 0.96895808 |
| 59 | CSK | 0.95872535 |
| 60 | TGFBR1 | 0.92152270 |
| 61 | STK4 | 0.88041882 |
| 62 | JAK2 | 0.87276454 |
| 63 | OXSR1 | 0.79682644 |
| 64 | MAP3K12 | 0.76488745 |
| 65 | FES | 0.76013594 |
| 66 | ACVR1B | 0.74117082 |
| 67 | DDR2 | 0.72641156 |
| 68 | KDR | 0.72322611 |
| 69 | GRK1 | 0.72071493 |
| 70 | PINK1 | 0.71743430 |
| 71 | PKN1 | 0.70026240 |
| 72 | ABL2 | 0.69976382 |
| 73 | ADRBK2 | 0.67192270 |
| 74 | TNK2 | 0.67112427 |
| 75 | ADRBK1 | 0.66055246 |
| 76 | MAP3K5 | 0.63604823 |
| 77 | PRKCD | 0.62523874 |
| 78 | MYLK | 0.61604560 |
| 79 | CDC42BPA | 0.60249076 |
| 80 | MAPK7 | 0.60178999 |
| 81 | BMX | 0.57708870 |
| 82 | SIK3 | 0.56851339 |
| 83 | STK10 | 0.56360599 |
| 84 | YES1 | 0.56203150 |
| 85 | ERBB3 | 0.54188228 |
| 86 | IRAK2 | 0.52843326 |
| 87 | MUSK | 0.51096889 |
| 88 | LRRK2 | 0.50834797 |
| 89 | MAP2K3 | 0.49916835 |
| 90 | MAPKAPK2 | 0.49411770 |
| 91 | STK16 | 0.48773029 |
| 92 | PTK2B | 0.47763869 |
| 93 | GRK7 | 0.46844891 |
| 94 | MELK | 0.46395385 |
| 95 | MAP3K11 | 0.46154851 |
| 96 | ABL1 | 0.45671700 |
| 97 | PDK2 | 0.45238173 |
| 98 | MOS | 0.44089226 |
| 99 | TAOK1 | 0.41649772 |
| 100 | FER | 0.41582782 |
| 101 | BMPR1B | 0.41582639 |
| 102 | IGF1R | 0.40326885 |
| 103 | GRK6 | 0.40252005 |
| 104 | PRKCQ | 0.39049124 |
| 105 | HIPK2 | 0.39024883 |
| 106 | PDK1 | 0.38856147 |
| 107 | CAMKK2 | 0.37200313 |
| 108 | RPS6KA5 | 0.36888906 |
| 109 | BCKDK | 0.36464880 |
| 110 | RIPK1 | 0.35727644 |
| 111 | MAPK11 | 0.35691694 |
| 112 | CAMK1D | 0.34354564 |
| 113 | GRK5 | 0.34297062 |
| 114 | PRKCE | 0.34203143 |
| 115 | DYRK3 | 0.34104930 |
| 116 | MAP2K6 | 0.33976734 |
| 117 | PRKG2 | 0.33862897 |
| 118 | TAF1 | 0.33567474 |
| 119 | PTK6 | 0.32106083 |
| 120 | STK24 | 0.31287317 |
| 121 | RPS6KA6 | 0.30820467 |
| 122 | RAF1 | 0.29744700 |
| 123 | STK3 | 0.29009558 |
| 124 | PRKAA2 | 0.28596054 |
| 125 | TTN | 0.28411814 |
| 126 | EGFR | 0.26267015 |
| 127 | DAPK3 | 0.25468586 |
| 128 | NUAK1 | 0.25338688 |
| 129 | ITK | 0.24284258 |
| 130 | RPS6KA1 | 0.22829545 |
| 131 | PIK3CG | 0.22316113 |
| 132 | MARK3 | 0.21270670 |
| 133 | BCR | 0.20275793 |
| 134 | DYRK1B | 0.19365493 |
| 135 | EIF2AK3 | 0.17720821 |
| 136 | EIF2AK1 | 0.16193189 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 4.01195364 |
| 2 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.59804770 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.46106889 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 3.12244994 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 3.04406248 |
| 6 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 3.04258474 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.74954238 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.62359644 |
| 9 | * Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.55796654 |
| 10 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.45352205 |
| 11 | Influenza A_Homo sapiens_hsa05164 | 2.31386768 |
| 12 | Legionellosis_Homo sapiens_hsa05134 | 2.18350418 |
| 13 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.16058258 |
| 14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.13460917 |
| 15 | Pertussis_Homo sapiens_hsa05133 | 2.12878071 |
| 16 | * Herpes simplex infection_Homo sapiens_hsa05168 | 2.09123053 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.02443267 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.00489779 |
| 19 | Asthma_Homo sapiens_hsa05310 | 1.98945708 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.95425993 |
| 21 | Malaria_Homo sapiens_hsa05144 | 1.91682007 |
| 22 | * TNF signaling pathway_Homo sapiens_hsa04668 | 1.84028405 |
| 23 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.83216987 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.78541765 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.66083883 |
| 26 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.64348434 |
| 27 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.61430002 |
| 28 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.58770405 |
| 29 | Viral myocarditis_Homo sapiens_hsa05416 | 1.54107538 |
| 30 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.50702191 |
| 31 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.50033171 |
| 32 | Apoptosis_Homo sapiens_hsa04210 | 1.41240419 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.39172645 |
| 34 | Salmonella infection_Homo sapiens_hsa05132 | 1.33591908 |
| 35 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.32769800 |
| 36 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.27303660 |
| 37 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.26994310 |
| 38 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.25991626 |
| 39 | Shigellosis_Homo sapiens_hsa05131 | 1.25563288 |
| 40 | Hepatitis C_Homo sapiens_hsa05160 | 1.20952710 |
| 41 | Hepatitis B_Homo sapiens_hsa05161 | 1.16241613 |
| 42 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.14162405 |
| 43 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.10683072 |
| 44 | Other glycan degradation_Homo sapiens_hsa00511 | 0.98440261 |
| 45 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.88871898 |
| 46 | Lysosome_Homo sapiens_hsa04142 | 0.88522771 |
| 47 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.82914972 |
| 48 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.82870984 |
| 49 | Phagosome_Homo sapiens_hsa04145 | 0.82774759 |
| 50 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.81583662 |
| 51 | Proteasome_Homo sapiens_hsa03050 | 0.80415939 |
| 52 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.77167367 |
| 53 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.73794654 |
| 54 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.73227086 |
| 55 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.72891168 |
| 56 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.72744181 |
| 57 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.71671761 |
| 58 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.69989814 |
| 59 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.69598547 |
| 60 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.68970904 |
| 61 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.68462139 |
| 62 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.67298483 |
| 63 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.66474747 |
| 64 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.63634490 |
| 65 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.61506314 |
| 66 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.59055783 |
| 67 | Ribosome_Homo sapiens_hsa03010 | 0.58451325 |
| 68 | Amoebiasis_Homo sapiens_hsa05146 | 0.55798215 |
| 69 | Platelet activation_Homo sapiens_hsa04611 | 0.55347887 |
| 70 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.54769151 |
| 71 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.53632309 |
| 72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51417146 |
| 73 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.50899768 |
| 74 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.50260918 |
| 75 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.46498307 |
| 76 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.45749147 |
| 77 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.45191133 |
| 78 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44698100 |
| 79 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.44390277 |
| 80 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.44176403 |
| 81 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.43945304 |
| 82 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.41047143 |
| 83 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.39998808 |
| 84 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.38954651 |
| 85 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.38599338 |
| 86 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.38070690 |
| 87 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.37163779 |
| 88 | Phototransduction_Homo sapiens_hsa04744 | 0.36850338 |
| 89 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.35829933 |
| 90 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.35438668 |
| 91 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.33505295 |
| 92 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.30457847 |
| 93 | Prion diseases_Homo sapiens_hsa05020 | 0.29693059 |
| 94 | Mineral absorption_Homo sapiens_hsa04978 | 0.27287015 |
| 95 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.26003359 |
| 96 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.25545180 |
| 97 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.24737707 |
| 98 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.24708071 |
| 99 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.24294334 |
| 100 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.21838224 |
| 101 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.20605390 |
| 102 | Base excision repair_Homo sapiens_hsa03410 | 0.19203068 |
| 103 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.18666274 |
| 104 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.18624892 |
| 105 | DNA replication_Homo sapiens_hsa03030 | 0.18612164 |
| 106 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.18274116 |
| 107 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.17886603 |
| 108 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.17810072 |
| 109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.17396222 |
| 110 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.17066181 |
| 111 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.16561261 |
| 112 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.15671678 |
| 113 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.13987733 |
| 114 | Insulin resistance_Homo sapiens_hsa04931 | 0.13712306 |
| 115 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.12431676 |
| 116 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.11946382 |
| 117 | Galactose metabolism_Homo sapiens_hsa00052 | 0.10984646 |
| 118 | Olfactory transduction_Homo sapiens_hsa04740 | 0.09881325 |
| 119 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.08955142 |
| 120 | ABC transporters_Homo sapiens_hsa02010 | 0.08938866 |
| 121 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.08410124 |
| 122 | Peroxisome_Homo sapiens_hsa04146 | 0.08213580 |
| 123 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.07770987 |
| 124 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.04273801 |
| 125 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.03843310 |

